KRAS and colorectal carcinoma: Moreover, our qPCR and Western blot assay results further showed that when comparing the PRMT5 expression of the KRAS mutant CRC cells to the KRAS WT CRC cells, the KRAS mutant CRC cells showed a further overexpression of PRMT5 at both the transcriptional and translational levels [27].